Zobrazeno 1 - 10
of 63
pro vyhledávání: '"M, Ellen Kuenzig"'
Autor:
Jennifer J. Y. Lee, Sasha Bernatsky, Eric I. Benchimol, M. Ellen Kuenzig, Jeffrey C. Kwong, Qing Li, Jessica Widdifield
Publikováno v:
BMC Gastroenterology, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background and aims There is an incomplete understanding of the full safety profiles of repeated COVID-19 vaccinations in patients with inflammatory bowel disease (IBD). Among individuals with IBD, we assessed whether COVID-19 vaccines were
Externí odkaz:
https://doaj.org/article/ddcc7eb231cb4fc39927b009a554956c
Publikováno v:
BMC Gastroenterology, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background Life expectancy in people with inflammatory bowel disease (IBD) has increased but remains shorter than in people without IBD. We describe the life expectancy associated with IBD therapies among the growing number of older adults l
Externí odkaz:
https://doaj.org/article/8f9979cfa52f42a5974bde68785baa19
Autor:
Michael Elten, Eric I. Benchimol, Deshayne B. Fell, M. Ellen Kuenzig, Glenys Smith, Hong Chen, Gilaad G. Kaplan, Eric Lavigne
Publikováno v:
Environment International, Vol 138, Iss , Pp - (2020)
Background: High-income nations have the highest rates of inflammatory bowel disease (IBD). The incidence of pediatric-onset IBD is increasing faster than IBD diagnosed in older individuals. Previous epidemiological studies have shown that air pollut
Externí odkaz:
https://doaj.org/article/78cf838a329a410889fff1eca2415d1a
Autor:
M. Ellen Kuenzig, Jeff Yim, Stephanie Coward, Bertus Eksteen, Cynthia H. Seow, Cheryl Barnabe, Herman W. Barkema, Mark S. Silverberg, Peter L. Lakatos, Paul L. Beck, Richard Fedorak, Levinus A. Dieleman, Karen Madsen, Remo Panaccione, Subrata Ghosh, Gilaad G. Kaplan
Publikováno v:
EBioMedicine, Vol 21, Iss C, Pp 188-196 (2017)
Background: NOD2 and smoking are risk factors for Crohn's disease. We meta-analyzed NOD2-smoking interactions in Crohn's disease (Phase 1), then explored the effect of age at diagnosis on NOD2-smoking interactions (Phase 2). Methods: Phase 1: MEDLINE
Externí odkaz:
https://doaj.org/article/356c21b845b8434e9f3ffc98edc2a706
Autor:
M Ellen, Kuenzig, Eric I, Benchimol, Charles N, Bernstein, Alain, Bitton, Matthew W, Carroll, Anne M, Griffiths, Gilaad G, Kaplan, Geoffrey C, Nguyen, Anthony R, Otley, Therese A, Stukel, Trevor J B, Dummer, Wael, El-Matary, Kevan, Jacobson, Jennifer L, Jones, Lisa M, Lix, David R, Mack, Sanjay K, Murthy, Juan-Nicolás, Peña-Sánchez, Laura E, Targownik, Stephen G, Fung, Sarah, Spruin, Stephanie, Coward, Yunsong, Cui, Christopher, Filliter, Zoann, Nugent, Shabnaz, Siddiq, Harminder, Singh
Publikováno v:
Journal of Pediatric Gastroenterology & Nutrition. 75:173-180
Several studies have demonstrated higher rates of Clostridioides difficile infection (CDI) in adults with inflammatory bowel disease (IBD). We conducted a population-based study comparing the risk of hospitalization with CDI in children with and with
Autor:
M Ellen, Kuenzig, Eric I, Benchimol
Publikováno v:
Journal of Pediatric Gastroenterology & Nutrition. 75:116-119
Pediatric inflammatory bowel disease (IBD) is becoming increasingly common around the world, rapidly accelerating in regions undergoing rapid economic development. IBD is more common among those living in cities, and the association between the urban
Autor:
Michael J Buie, Stephanie Coward, Abdel-Aziz Shaheen, Jayna Holroyd-Leduc, Lindsay Hracs, Christopher Ma, Remo Panaccione, Eric I Benchimol, Charles N Bernstein, Alain Bitton, Anthony R Otley, Jennifer L Jones, Sanjay K Murthy, M Ellen Kuenzig, Juan-Nicolás Peña-Sánchez, Laura E Targownik, Harminder Singh, Antonio Avina-Zubieta, Gilaad G Kaplan
Publikováno v:
Inflammatory Bowel Diseases.
Background Recent advances in the management of inflammatory bowel disease (IBD) striving for new treatment targets may have decreased rates of hospitalization for flares. We compared all-cause, IBD-related, and non-IBD-related hospitalizations while
Autor:
M. Ellen Kuenzig, Eric I. Benchimol
Publikováno v:
Pediatric Inflammatory Bowel Disease ISBN: 9783031147432
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7fc347e8e75f9b126386318ee049d980
https://doi.org/10.1007/978-3-031-14744-9_6
https://doi.org/10.1007/978-3-031-14744-9_6
Autor:
M Ellen Kuenzig, Laura E Targownik, Gilaad G. Kaplan, Usha Chauhan, Lisa Barrett, Joseph W. Windsor, John Marshall, Stephanie Coward, Kate Lee, Anne M. Griffiths, David R. Mack, Deanna L. Gibson, Sharyle Fowler, Sanjay K. Murthy, Sandra Zelinsky, Jennifer Jones, Janet Crain, Remo Panaccione, Eric I Benchimol, Reena Khanna, Jean-Eric Ghia, Alain Bitton, Charles N. Bernstein, Mina Mawani, Cynthia H. Seow, Peter L. Lakatos
Publikováno v:
Journal of the Canadian Association of Gastroenterology
The prevalence of inflammatory bowel diseases (IBD), Crohn’s disease and ulcerative colitis, in Canada, is over 0.75% in 2021. Many individuals with IBD are immunocompromised. Consequently, the World Health Organization’s declaration of a global
Autor:
Gilaad G. Kaplan, Parul Tandon, Kate Lee, Laura E Targownik, Mariam S Mukhtar, Alain Bitton, Remo Panaccione, M Ellen Kuenzig, James Guoxian Huang, Sanjay K. Murthy, Eric I Benchimol, Joseph W. Windsor, Jennifer Jones, Charles N. Bernstein, Peter L. Lakatos
Publikováno v:
Journal of the Canadian Association of Gastroenterology
Inflammatory bowel disease (IBD) is a disease that results from dysregulation of the immune system and frequently requires medications that can affect the immune response to infections; therefore, it was imperative to quickly understand the risk of c